Skip to main content
Equibles

Legal & General Group Plc

Position in GERN — Geron Corp

CIK 764068 London, X0
Back to GERN Full portfolio

Position in GERN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$396,218
-$46,074 QoQ
Shares Held
309,547
+4.3% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GERN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. GERN ranks #146 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in GERN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $396,218 309,547
2026-03-31 $442,292 296,841
2025-12-31 $585,192 443,328
2025-09-30 $695,821 507,900
2025-06-30 $776,726 550,871
2025-03-31 $808,555 508,526
2024-12-31 $1,801,405 508,872
2024-09-30 $2,046,749 450,826
2024-06-30 $1,724,215 406,655
2024-03-31 $1,306,971 396,052
2023-12-31 $865,989 410,422
2023-09-30 $869,420 410,104
2023-06-30 $1,292,906 402,775
2023-03-31 $380,508 175,350
2022-12-31 $356,172 147,179
2022-09-30 $331,954 141,861
2022-06-30 $212,691 137,221
2022-03-31 $143,657 105,631
2021-12-31 $128,869 105,631
2021-09-30 $144,714 105,631
2021-06-30 $82,366 58,416
2021-03-31 $98,797 62,531
2020-12-31 $92,880 58,416
2020-09-30 $101,643 58,416
2020-06-30 $95,416 43,769
2020-03-31 $52,084 43,769